Hypoxia-responsive gene expression systems have been developed to produce the angiogenic vascular endothelial growth factor (VEGF) and improve hypoxia and malnutrition in artificial 3D tissues [9,10]. The gene discussed is VEGFA; the disease is nutritional deficiency disease.